SCHEMBL29417833

SCHEMBL29417833

CC(C)(C)OC(=O)N1CCC(N2C(=O)CNc3cc(C4CCOCC4)cnc32)CC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DDB1 Q16531 2/20 0.42
CRBN Q96SW2 2/20 0.42
RECQL P46063 1/20 0.41
KDM4E B2RXH2 1/20 0.40
MAPT P10636 1/20 0.40
THRB P10828 1/20 0.40
GPR119 Q8TDV5 4/20 0.40
PIK3CA P42336 3/20 0.39
MTOR P42345 2/20 0.39
PIK3CG P48736 1/20 0.39
ATR Q13535 1/20 0.39
AURKB Q96GD4 1/20 0.39
IDH1 O75874 1/20 0.38
CTSD P07339 1/20 0.38
CTSE P14091 1/20 0.38
BACE1 P56817 1/20 0.38
USP30 Q70CQ3 1/20 0.38
WNT3A P56704 1/20 0.37
HCAR1 Q9BXC0 1/20 0.37
USP2 O75604 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29417834 0.84 GPR119 (0.43) DDB1CRBNKDM4EMAPTTHRB
SCHEMBL31197447 0.75 DDB1 (0.45) DDB1CRBNRECQLKDM4EMAPT
SCHEMBL29417828 0.75 RECQL (0.43) DDB1CRBNRECQLKDM4EMAPT
SCHEMBL20996019 0.72 CTSD (0.47) KDM4EMAPTTHRBGPR119PIK3CA
SCHEMBL29417844 0.72 CTSD (0.47) KDM4EMAPTTHRBGPR119PIK3CA
SCHEMBL31197474 0.72 USP30 (0.43) DDB1CRBNRECQLKDM4EMAPT
SCHEMBL31197488 0.70 DDB1 (0.42) DDB1CRBNRECQLKDM4EMAPT
SCHEMBL31197440 0.70 DDB1 (0.45) DDB1CRBNRECQLMAPTGPR119
SCHEMBL31585430 0.70 DDB1 (0.53) DDB1CRBNKDM4EMAPTTHRB
SCHEMBL12524380 0.69 GPR119 (0.58) DDB1CRBNRECQLKDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022051567-A1 SUBSTITUTED PYRIDO[2,3-B]PYRAZINONES AND REUATED COMPOUNDS AND THEIR USE IN TREATING MEDICAU CONDITIONS Ikena Oncology, Inc. (US) 2022-03-10 WO disclosed